'Breast cancer mortality' diaporamas de présentation

BREAST CANCER 101 A Review of Problems, Diagnostics, and CLINICAL MANAGEMENT

Sabha Ganai, MD, PhD Assistant Professor of Surgery Southern Illinois University School of Medicine. BREAST CANCER 101 A Review of Problems, Diagnostics, and CLINICAL MANAGEMENT. My conflicts of interest are relevant to being a practicing surgical oncologist. DISCLOSURES. Objectives.

765 views • 53 slides

562 views • 53 slides

603 views • 40 slides

Putting Prevention into Practice

449 views • 34 slides

Putting Prevention into Practice

467 views • 34 slides

Update on the Belgian Cancer Registry, breast cancer data...

Update on the Belgian Cancer Registry, breast cancer data. Belgian Breast Meeting 3-4/10/2008 Liesbet Van Eycken. Overview. Introduction, history of the BCR Breast Cancer Incidence - Mortality Europe Belgium Flanders. 1983 NKR-RNC. 2002 CIV IACR Flemish Network.

528 views • 30 slides

Emerging Issues in Cancer Control :

352 views • 19 slides

Jo Anne Zujewski, MD Clinical Investigations Branch Cancer Therapy Evaluation Program

The Global Burden of Breast Cancer. Jo Anne Zujewski, MD Clinical Investigations Branch Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment May 2011. Breast Cancer: Most common cancer in developed and developing world. 1.38 million cases in 2008

348 views • 16 slides

50 Shades of Pink

50 Shades of Pink. From your Oxford Centric team. Mississippi: Now and Beyond. Breast cancer is the 2 nd leading cause of death in Mississippi. Mississippi is 3 rd in breast cancer mortality. 1,990 new breast cancer cases are predicted for Mississippi. The Risk.

239 views • 13 slides

Ethnic Differences in Breast Cancer Incidence and Mortality in the US-Mexico Border States

Ethnic Differences in Breast Cancer Incidence and Mortality in the US-Mexico Border States. Susanna Valenzuela New Mexico State University Graduate Student in Applied Statistics. Fred Hutch Cancer Research Intern. Comparison of Outcomes Following Allogeneic Hematopoietic Cell Transplant.

109 views • 10 slides

Time to Distant Metastases (ITT)

Time to Distant Metastases (ITT). Cumulative incidence of distant metastases (ITT). 0.10. Tamoxifen Exemestane. 0.08. 0.06. Probability. 0.04. 0.02. HR 0.81 (0.67-0.98; P <0.03). 0.00. 0.0. 0.5. 1.0. 1.5. 2.0. 2.5. Years since randomization. 4868. 26/4771. 69/4652. 53/4547.

158 views • 4 slides